Research centers on nucleic acid–guided biosensing using nanoparticle plasmonics and electrochemical transduction to create rapid, extraction‑free, point‑of‑care diagnostics. Work spans probe design, self‑assembly, and device integration, enabling multiplexed, clinically benchmarked assays across infectious disease and oncology.